BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32852875)

  • 1. Risk for lymph node metastasis in Epstein-Barr virus-associated gastric carcinoma with submucosal invasion.
    Tsuji Y; Ushiku T; Shinozaki T; Yamashita H; Seto Y; Fukayama M; Fujishiro M; Oda I; Katai H; Taniguchi H; Hasatani K; Kaizaki Y; Oga A; Nishikawa J; Akasaka R; Endo M; Sugai T; Matsumoto T; Koike K
    Dig Endosc; 2021 May; 33(4):592-597. PubMed ID: 32852875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus status is a promising biomarker for endoscopic resection in early gastric cancer: proposal of a novel therapeutic strategy.
    Osumi H; Kawachi H; Yoshio T; Ida S; Yamamoto N; Horiuchi Y; Ishiyama A; Hirasawa T; Tsuchida T; Hiki N; Takeuchi K; Fujisaki J
    J Gastroenterol; 2019 Sep; 54(9):774-783. PubMed ID: 30826866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of Epstein-Barr virus status on the incidence of lymph node metastasis in early gastric cancer.
    Osumi H; Kawachi H; Yoshio T; Fujisaki J
    Dig Endosc; 2020 Mar; 32(3):316-322. PubMed ID: 31762090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification for lymph node metastasis using Epstein-Barr virus status in submucosal invasive (pT1) gastric cancer without lymphovascular invasion: a multicenter observational study.
    Osumi H; Kawachi H; Murai K; Kusafuka K; Inoue S; Kitamura M; Yoshio T; Kakusima N; Ishihara R; Ono H; Yamamoto N; Sugino T; Nakatsuka S; Ida S; Nunobe S; Bando E; Omori T; Takeuchi K; Fujisaki J
    Gastric Cancer; 2019 Nov; 22(6):1176-1182. PubMed ID: 31062195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer.
    Park JH; Kim EK; Kim YH; Kim JH; Bae YS; Lee YC; Cheong JH; Noh SH; Kim H
    Gastric Cancer; 2016 Oct; 19(4):1041-1051. PubMed ID: 26573601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very low risk of lymph node metastasis in Epstein-Barr virus-associated early gastric carcinoma with lymphoid stroma.
    Cheng Y; Zhou X; Xu K; Huang J; Huang Q
    BMC Gastroenterol; 2020 Aug; 20(1):273. PubMed ID: 32807085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with undifferentiated early gastric cancer.
    Liang XQ; Wang Z; Li HT; Ma G; Yu WW; Zhou HC; Liu HB
    Asian J Surg; 2020 Oct; 43(10):973-977. PubMed ID: 31964584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of endoscopic treatment and predictors of lymph node metastasis in early gastric cancer.
    Chu YN; Yu YN; Jing X; Mao T; Chen YQ; Zhou XB; Song W; Zhao XZ; Tian ZB
    World J Gastroenterol; 2019 Sep; 25(35):5344-5355. PubMed ID: 31558878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic features of early gastric carcinoma with lymphoid stroma and feasibility of endoscopic submucosal dissection.
    Shin DH; Kim GH; Lee BE; Lee JW; Ha DW; Jeon HK; Baek DH; Song GA; Ahn SJ; Park DY
    Surg Endosc; 2017 Oct; 31(10):4156-4164. PubMed ID: 28409376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of an Undifferentiated Component in Submucosal Invasion and Submucosal Invasion Depth After Endoscopic Submucosal Dissection for Early Gastric Cancer.
    Miyahara K; Hatta W; Nakagawa M; Oyama T; Kawata N; Takahashi A; Yoshifuku Y; Hoteya S; Hirano M; Esaki M; Matsuda M; Ohnita K; Shimoda R; Yoshida M; Dohi O; Takada J; Tanaka K; Yamada S; Tsuji T; Ito H; Aoyagi H; Shimosegawa T
    Digestion; 2018; 98(3):161-168. PubMed ID: 29870985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictive factors for lymph node metastasis in patients with poorly differentiated early gastric cancer].
    Pang BR; Zhu ZL; Li C; Liu WT; KumarSah RD; Yan M; Zhu ZG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 May; 22(5):446-450. PubMed ID: 31104430
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term oncological outcomes of submucosal manipulation during non-curative endoscopic submucosal dissection for submucosal invasive gastric cancer: a multicenter retrospective study in Japan.
    Ito H; Gotoda T; Oyama T; Kawata N; Takahashi A; Yoshifuku Y; Hoteya S; Nakagawa M; Hatta W; Hirano M; Esaki M; Matsuda M; Ohnita K; Shimoda R; Yoshida M; Dohi O; Takada J; Tanaka K; Yamada S; Tsuji T; Hayashi Y; Nakaya N; Nakamura T; Shimosegawa T
    Surg Endosc; 2018 Jan; 32(1):196-203. PubMed ID: 28639037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional laparoscopic gastrectomy after noncurative endoscopic submucosal dissection for early gastric cancer: A single-center experience.
    Tian YT; Ma FH; Wang GQ; Zhang YM; Dou LZ; Xie YB; Zhong YX; Chen YT; Xu Q; Zhao DB
    World J Gastroenterol; 2019 Aug; 25(29):3996-4006. PubMed ID: 31413533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying predictors of lymph node metastasis after endoscopic resection in patients with minute submucosal cancer of the stomach.
    Choi JY; Park YS; Jung HY; Son DH; Ahn JY; Han S; Lim H; Choi KS; Lee JH; Kim DH; Choi KD; Song HJ; Lee GH; Kim JH
    Surg Endosc; 2015 Jun; 29(6):1476-83. PubMed ID: 25249150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of lymph node metastasis or lymphovascular invasion for early gastric cancer: a practical and effective predictive model based on international multicenter data.
    Lin JX; Wang ZK; Wang W; Desiderio J; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Li P; Parisi A; Zhou ZW; Huang CM
    BMC Cancer; 2019 Nov; 19(1):1048. PubMed ID: 31694573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of lymph node metastasis in 1620 early gastric carcinoma radical resections in Jiangsu Province in China: A multicenter clinicopathological study.
    Chen L; Wang YH; Cheng YQ; Du MZ; Shi J; Fan XS; Zhou XL; Zhang YF; Guo LC; Xu GF; He YM; Zhou D; Zou XP; Huang Q; Team TJPEGCMS
    J Dig Dis; 2017 Oct; 18(10):556-565. PubMed ID: 28949436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
    Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
    Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node metastasis can be determined by just tumor depth and lymphovascular invasion in early gastric cancer patients after endoscopic submucosal dissection.
    Goto A; Nishikawa J; Hideura E; Ogawa R; Nagao M; Sasaki S; Kawasato R; Hashimoto S; Okamoto T; Ogihara H; Hamamoto Y; Sakaida I
    Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1346-1350. PubMed ID: 29084076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal extent of lymph node dissection in patients with gastric cancer who underwent non-curative endoscopic submucosal dissection with a positive vertical margin.
    Furukawa K; Kamiya S; Sugino T; Aizawa D; Kawabata T; Notsu A; Hikage M; Tanizawa Y; Bando E; Takizawa K; Ono H; Terashima M
    Eur J Surg Oncol; 2020 Dec; 46(12):2229-2235. PubMed ID: 32788095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is endoscopic resection an alternative to surgery for early low-risk submucosal gastric cancers: analysis of a large surgical database.
    Tae CH; Pouw RE; Duits LC; Sung YK; Min BH; Lee JH; Rhee PL; Kim KM; Bergman JJ; Kim JJ
    Surg Endosc; 2015 Jun; 29(6):1614-20. PubMed ID: 25294538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.